Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Study Phase
Phase 3
Study Completion Date
December 2019
NCT01196390Uploaded 05-02-2023
Access via NCI by Request
PDS UID: nci-data-520
A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma
Files: NCT01196390-D1
Data DictionaryNCT01196390-D1-Data-Dictionary_1.pdf
Files: NCT01196390-D2
Data DictionaryNCT01196390-D2-Data-Dictionary_1.pdf
Files: NCT01196390-D3
Data DictionaryNCT01196390-D3-Data-Dictionary_1.pdf